Developments on drug delivery systems for the treatment of mycobacterial infections

The clinical management of tuberculosis and other mycobacterial diseases with antimycobacterial chemotherapy remains a difficult task. The classical treatment protocols are long-lasting; the drugs reach mycobacteria-infected macrophages in low amounts and/or do not persist long enough to develop the...

Full description

Bibliographic Details
Main Author: Gaspar, M. M. (author)
Other Authors: Cruz, A. (author), Fraga, A. G. (author), Castro, António G. (author), Cruz, M. E. M. (author), Pedrosa, Jorge (author)
Format: article
Language:eng
Published: 2008
Subjects:
Anti-Bacterial Agents
Humans
Liposomes
Mycobacterium Infections
Nanoparticles
Drug Delivery Systems
Mycobacterium tuberculosis
M. avium
drug delivery
Ciências Médicas::Medicina Básica
Science & Technology
Online Access:http://hdl.handle.net/1822/61464
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/61464

Internet

http://hdl.handle.net/1822/61464

Similar Items